These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy. Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270 [No Abstract] [Full Text] [Related]
4. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia. Medoff G; Valeriote F; Lynch RG; Schlessinger D; Kobayashi GS Cancer Res; 1974 May; 34(5):974-8. PubMed ID: 4823906 [No Abstract] [Full Text] [Related]
5. [Experimental model for the study of antitumor immunity combined action drugs]. Fioretti MC; Bonmassar E G Ital Chemioter; 1979; 26(1-2):357-62. PubMed ID: 554824 [No Abstract] [Full Text] [Related]
6. The effects of chemotherapy on the kinetics of leukemic cell behavior. Skipper HE Cancer Res; 1965 Oct; 25(9):1544-50. PubMed ID: 5861078 [No Abstract] [Full Text] [Related]
7. Experimental chemotherapy of rat leukemia RBA-Le with cis-diamminedichloroplatinum. Kovarík J; Svec F; Zemanová D Neoplasma; 1977; 24(5):475-86. PubMed ID: 270616 [TBL] [Abstract][Full Text] [Related]
8. Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vivo. Wodinsky I; Swiniarski J; Kensler CJ; Venditti JM Cancer Chemother Rep 2; 1974 Mar; 4(1):73-97. PubMed ID: 4826500 [No Abstract] [Full Text] [Related]
9. Potentiation of anticancer agents by amphotericin B. Medoff G; Valeriote F; Dieckman J J Natl Cancer Inst; 1981 Jul; 67(1):131-5. PubMed ID: 6942183 [TBL] [Abstract][Full Text] [Related]
10. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. Razek A; Vietti T; Valeriote F Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737 [No Abstract] [Full Text] [Related]
11. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871 [No Abstract] [Full Text] [Related]
12. Perturbation of leukemic cell population in AKR mice due to chemotherapy. Omine M; Perry S Cancer Res; 1973 Nov; 33(11):2596-602. PubMed ID: 4748424 [No Abstract] [Full Text] [Related]
13. An experimental model for meningeal leukemia in rats (L5222). Effect of treatment with BCNU and cyclophosphamide. Fiebig HH; Zeller WH; Schmähl D Int J Cancer; 1976 Nov; 18(5):710-6. PubMed ID: 992902 [TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental mouse hemoblastosis. VII. Time course of change in the frequency of mitoses of leukaemic leukocytes (L 14 AKR and LaH VUFB) after administration of methotrexate. Motycka K; Stránská E; Andrysek O; Coufalová H; Jehlicková M Neoplasma; 1970; 17(2):137-42. PubMed ID: 5425391 [No Abstract] [Full Text] [Related]
15. Potentiation of cytotoxicity of anticancer agents by several different polyene antibiotics. Valeriote F; Medoff G; Dieckman J J Natl Cancer Inst; 1984 Feb; 72(2):435-9. PubMed ID: 6582328 [TBL] [Abstract][Full Text] [Related]
16. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia. Pearson JW; Chaparas SD; Chirigos MA Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796 [No Abstract] [Full Text] [Related]
17. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice. Budzyński W Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488 [TBL] [Abstract][Full Text] [Related]
18. Analysis of tests of chemotherapeutic agents involving repeated drug treatment. Ullman NS; Jacquez JA Biometrics; 1973 Dec; 29(4):677-93. PubMed ID: 4785233 [No Abstract] [Full Text] [Related]
19. Adoptive immunotherapy and combined chemo-immunotherapy in transplantable leukaemia of AKR mice (TAL); occurrence of natural killers. Schneiberg K; Rytwiński K; Tabeńska J Haematologia (Budap); 1981; 14(2):137-46. PubMed ID: 7274781 [TBL] [Abstract][Full Text] [Related]
20. Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency. Medoff G; Valeriote F; Ryan J; Tolen S J Natl Cancer Inst; 1977 Apr; 58(4):949-53. PubMed ID: 845998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]